Drug adherence and treatment duration for denosumab and mortality risk among hip fracture patients
Yi‐Lun Tsai, Chih‐Hsing Wu, Chia‐Chun Li, Chien‐An Shih, Yin‐Fan Chang, Jawl‐Shan Hwang, Ta‐Wei Tai
Topics & Concepts
MedicineDenosumabHazard ratioOsteoporosisHip fractureInternal medicineConfidence intervalCohort studyPopulationCohortSurgeryEnvironmental healthHip and Femur FracturesBone health and osteoporosis researchBone health and treatments